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Background: Despite the progress in research, the utility of clinical assessment for the 
prediction of stroke is limited. The aim herein, was to evaluate the predictive values of major 
ultrasound indexes of carotid artery and fat depots for stroke in patients with high and  very 
high cardiovascular (CV) risk. 
Methods: The study group included 364 patients (age: 61.3 ± 7.2 years old) with typical CV 
risk factors scheduled for elective coronary angiography (2012–2013). A comprehensive 
baseline assessment included the following ultrasound indexes: carotid artery intima-media 
thickness (IMT), extra-media thickness (EMT), epicardial (EFT) and pericardial fat thickness 
(PFT), abdominal subcutaneous (ASF) and visceral fat (AVF) and combined Periarterial 
Adipose Tissue Intima Media Adventitia (PATIMA) index. Afterwards, all patients were 
followed for 80.9 ± 7.1 months. 
Results: There were 23 strokes and 25 cases with new-onset atrial fibrillation during follow-
up. Receiver operating characteristics (ROC) analysis showed, that selected clinical 
parameters (age, waist circumference [WC], waist hip ratio [WHR]) and ultrasound indexes 
(EFT: area under curve [AUC] 0.672, p < 0.01 and PATIMA index: AUC 0.658, p < 0.01) 
were predictive for stroke. However, their predictive values showed no significant differences 
(p = NS). The baseline body mass index (BMI) was the only parameter, which showed a 
prediction for new-onset atrial fibrillation (BMI > 33 kg/m2: sensitivity 65%, specificity 
76%).   
Conclusions: It was found that age, WC and echocardiographic EFT revealed significant 
predictive values for stroke. Both WC and EFT showed a very high NPV suggesting that they 
should be implemented into the clinical practice as a tool affirming a very low risk of stroke.  
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Cerebrovascular disease is an important cause of disability and mortality in developed 
countries [1]. Atrial fibrillation (AF) is one of the major causes of ischemic stroke [2] and 
cardioembolism is the most frequent cause of cryptogenic events [3]. Obesity is another 
world-wide medical problem increasing the risk of several cardiovascular (CV) diseases and 
complications [4]. However, the estimation of CV risk in patients with several comorbidities 
is difficult. Obesity has a few phenotypes, which are associated with different risk, especially 
in patients with chronic CV diseases [5]. This is explained by fat depots with a more or less 
active role in metabolism or local pathophysiology of arterial wall or heart muscle [6]. 
Previous studies showed that perivascular fat thickness is associated with cardiometabolic risk 
[7–9], peripheral atherosclerosis [10] and the severity of coronary artery disease [11, 12]. 
Whereas abdominal visceral adipose tissue is more associated with metabolic risk [9, 10].   
Despite the great progress in research, the utility of clinical assessment for the 
prediction of stroke is still limited. Therefore, the aim herein, was to evaluate the predictive 
values of major ultrasound indexes of carotid artery and fat depots for stroke in patients with 




All the consecutive patients (age: 50–75 years old) scheduled for CV diagnostics in the 
Department of Cardiology (2012–2013) were recruited to the study group. The following 
exclusion criteria were used at the screening: heart failure, significant heart valve defects, 
chronic inflammatory diseases, neoplastic diseases in the prior 5 years, secondary causes of 
obesity or prior interventions in obesity, a 10% unintentional weight loss, a poor carotid artery 
image quality and a genetic predisposition for CV diseases.   
Subjects completed the study at the Department of Cardiology at the Medical University of 
Silesia (SUM). The protocol was approved by the SUM Ethics Committee. This work was 
supported by a research non-commercial grant from the Medical University of Silesia (KNW-
1-029/N/8/K). 
Clinical characteristics  
A comprehensive clinical assessment and the following ultrasound indexes were 
obtained in all patients: abdominal subcutaneous fat (ASF), abdominal visceral fat (AVF), 
carotid intima-media thickness (IMT), carotid extra media thickness (EMT), epicardial fat 
thickness (EFT), pericardial fat thickness (PFT) and the periarterial adipose tissue intima 
media adventitia (PATIMA) index.   
Hyperlipidemia was determined based on plasma lipid levels or prior diagnosis and 
current treatment [13]. The diagnosis of hypertension was confirmed by the office blood 
pressure or prior diagnosis and current treatment [13]. Diabetes mellitus (DM) was reported in 
patients with prior diagnosis or abnormal fasting plasma glucose concentration (≥ 126 mg/dL) 
or HbA1c (≥ 6.5%) or 2-h post-load plasma glucose (≥ 200 mg/dL) in case of discrepancies 
[14, 15]. 
Obesity was classified according to body mass index (BMI = body mass (kg) / height 
(m)2) as normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2) and obesity (≥ 30.0 
kg/m2): class 1 (30.0–34.9 kg/m2), class 2 (35.0–39.9 kg/m2) and class 3 (≥ 40.0 kg/m2). 
Chronic kidney disease was determined based on estimated glomerular filtration rate (< 60 
mL/min/1.73 m2) or prior diagnosis and treatment. Waist circumference (WC: midpoint 
between the lowest rib and the iliac crest) and hip circumference (HC) were measured with a 
tape at the end of expiration. Coronary artery disease was defined as stenosis ≥ 50% in any 
major coronary artery assessed in coronary angiography. Finally, CV risk was estimated for 
each of the study patients based on the European Society of Cardiology guidelines [13]. 
 
Ultrasound indexes 
All the ultrasound scans were analyzed offline blinded to the patient’s data with the 
intra- and interobserver variability as shown previously [11]. 
 
Carotid artery indexes: IMT and EMT  
All the patients were in a supine position at the ECG-gated ultrasound examination of 
both carotid arteries (GE Vivid 9, Milwaukee, US — linear transducer 9–12 MHz). All the 
images were recorded by an experienced researcher using constant settings and once the 
recruitment was finished, images with the region of interest were analyzed offline blinded to 
patient’s data. Common carotid artery IMT was measured according to the Mannheim 
Consensus guidelines on a 10 mm-length segment starting 5 mm proximally to the carotid 
bulb using a semi-automated GE software [16]. Carotid IMT was an average value of both 
sides’ carotid arteries.   
Carotid EMT was measured in the images obtained in an alternative (to IMT) scanning 
of the carotid vessels and the method was described in our previous studies [11]. In brief, 
EMT is the distance between the carotid media-adventitia border and the jugular wall-lumen 
interface averaged from both common carotid arteries (CCA) with visualization of the 
zoomed interface between the near wall of the distal segment of the CCA and the neighboring 
jugular vein. It is measured manually in a standardized protocol including a 7 mm segment 
starting 3 mm proximal to the bulb. The mean EMT values were averaged from the serial 
measurements taken at end-diastole (5 consecutive beats) in both sides’ carotid arteries.  
 
Cardiac fat: EFT and PFT 
Epicardial adipose tissue (EFT) was evaluated using transthoracic echocardiography 
according to the most frequent and accepted method [17, 18]. Two-dimensional long and 
short axis parasternal views were obtained and recorded using GE Vivid 9 ultrasound machine 
with a 1.5–4.5 MHz transducer. The EFT was identified as an area between epicardium and 
visceral layer of the pericardium. The PFT was determined as an area between the visceral 
layer and parietal pericardium layer. Both (EFT and PFT) were measured perpendicularly to 
the right ventricle free wall at the level of the aortic annulus. The maximum values were 
measured both at the end-diastole during 5 consecutive beats and a mean value was obtained.    
 
Abdominal fat: ASF and AVF 
The transducer (7.5 MHz for ASF or 3.5 MHz for AVF) was placed on the skin (1 cm 
above umbilicus; transverse view) as lightly as possible to prevent compression of the layers 
and to perform a breath-hold measurements. The ASF was measured as the distance between 
the skin and external surface of the rectus abdominis muscle. The AVF was determined as the 
space between the internal surface of the rectus abdominis muscle and anterior wall of the 
aorta [7]. 
 
Ultrasound combined indexes  
All the ultrasound indexes (carotid IMT and EMT, cardiac EFT) were used in analysis 
as separate mean values. Each of them represents various tissue components and may 
correspond to different aspects of cardiovascular risk. Therefore, combined indexes 
(PATIMA) were used. The PATIMA index was developed recently [11] and it was calculated 
according to the following formula: PATIMA [u] = (EMT/BMI × 35) + IMT + (EFT × 60). 
 
Clinical follow-up 
All the clinical characteristics and ultrasound indexes were obtained prospectively at 
the time of enrollment (2012–2013). Afterwards, the Regional Branch of the National Health 
System (NHS) provided medical data regarding all the study patients. Data included inpatients 
and outpatients with the main diagnosis, concomitant diseases and treatment in the time 
period up to the end of 2019. A stroke was determined if it was either the main or concomitant 
diagnosis or a cause of death reported by the hospital or outpatient. A new-onset AF (NOAF) 
was determined if AF was reported in the follow-up time and was not present at the time of 
the study enrollment (2012–2013). Finally, NHS medical data regarding mortality was also 
collected. 
 
Statistical analysis   
All results presented in the text, tables and figure are expressed as means ± standard 
deviation or number and percentage. The results’ normal distribution was analyzed with the 
Kolmogorov-Smirnov test. Associations between parameters were assessed using the Pearson 
correlation analysis. To determine the best cut-off of particular clinical parameters or 
ultrasound indexes, the receiver operating characteristic (ROC) curves were used providing 
sensitivity, specificity, positive (PPV) and negative (NPV) predictive values for a stroke and a 
NOAF. Moreover, multivariable logistic regression models were employed to identify 
variables independently associated with follow-up events. A value p < 0.05 was considered 
statistically significant. Statistical analysis was undertaken using MedCalc (version 18.5, 
MedCalc Software).   
 
RESULTS 
Study group characteristics 
The study group included 364 patients (age: 61.3 ± 7.2 years old) with high or very 
high CV risk. All the patients used a standard pharmacotherapy, including beta-blockers 
(95%), acetylsalicylic acid (95%), lipid lowering treatment (100%) — statins (95%), fibrates 
(3%), ezetimibe (2%), angiotensin-converting enzyme inhibitors or angiotensin receptor 
blockers (86%), diuretics (30%), calcium channel blockers (26%) and nitrates (18%).  
The study patients revealed several CV risk factors as follows: dyslipidemia (100%), 
hypertension (89%), obesity (49%), diabetes (35%), and smoking (29%). Most patients had 
CAD (70%), one fifth (22%) had peripheral artery disease and carotid artery stenosis (≥ 50%) 
was found in 51 patients. Furthermore, 42 patients were found to have AF at baseline and 
medical history revealed prior myocardial infarction in 21% and stroke in 6% of the cases 
(Table 1).  
The mean measures of ultrasound indexes are presented in Table 2.  
The baseline carotid IMT showed a weak association with carotid EMT (r = 0.25, p < 
0.0001), PFT (r = 0.1, p = 0.01) and AVF (r = 0.1, p < 0.01). None of the other ultrasound 
indexes showed a significant association. Moreover, EFT showed a weak association with 
BMI (r = 0.2; p < 0.01) and no correlation with WHR (p = 0.8) or WC (p = 0.2). The 
PATIMA combined index also showed a weak association with BMI (r = 0.2; p = 0.001) and 
no association with WHR (p = 0.5) or WC (p = 0.8). 
Clinical prognosis and follow-up 
The baseline clinical characteristics and ultrasound indexes were used in the ROC 
analysis in prediction of stroke and NOAF. All the study patients were followed for 80.9 ± 7.1 
months. There were 50 deaths in the primary study group during follow-up. There were 23 
strokes in 23 patients (4 patients died) and 25 cases with NOAF during the follow-up. The 
ROC analysis showed, that selected clinical parameters (age, WC, WHR) and ultrasound 
indexes (EFT and PATIMA combined index) were predictive for stroke. Their predictive 
values showed no significant differences (p = NS). However, a multivariable logistic 
regression model including those five parameters showed that only EFT (odds ratio [OR] 1.4; 
95% confidence interval [CI] 0.5–2.3; p = 0.04) and PATIMA combined index (OR 2.1; 95% 
CI 1.01–4.22; p = 0.04). Finally, baseline BMI was the only parameter, which showed a 
prediction for NOAF, which occurred during a follow-up (BMI > 33 kg/m2: sensitivity 65%, 
specificity 76%, PPV 14%, NPV 97%; Table 3, Fig. 1).  
 
DISCUSSION 
This was the first prospective study providing a complete analysis of clinical risk 
factors and major ultrasound indexes in the prediction for stroke among patients with at least 
high CV risk. 
All the major ultrasound indexes were used, which are related to various tissue 
components, including subcutaneous or visceral adipose tissue, perivascular fat or various 
layers of the arterial wall. The associations between baseline single ultrasound indexes were 
either statistically or clinically not significant, which suggests that they are related to different 
aspects of CV risk. The echocardiography EFT was the only single ultrasound index, which 
predicted strokes during a 7-year prospective follow-up. Although the combined PATIMA 
index was also found to have significant predictions for strokes, it is a derivative of the EFT 
measure and its predictive value was not superior to the EFT alone. Finally, the baseline BMI 
was the only parameter with a prediction for NOAF and ultrasound indexes failed to predict 
AF. 
According to available research, the present study is the first to show that increased 
EFT (> 2.8 mm) was predictive for stroke in a prospective follow-up. Three small and cross-
sectional studies found a significantly higher EFT in patients with acute ischemic stroke 
compared to control groups [19–21]. Noteworthy, increased EFT was also found in young 
patients with embolic stroke of undetermined source [22]. Kyoung-Im et al. [23] showed that 
patients with ischemic stroke and AF had higher EFT compared to subjects with stroke, but 
without AF. In the current study, EFT had a high sensitivity and a very high NPV suggesting 
that values lower than 2.8 mm indicate a very low risk of stroke. Given that epicardial fat is 
involved in various atherosclerotic diseases, increased EFT is not specific only for increased 
risk of stroke. Moreover, the present study showed that obesity has an important relation with 
AF and strokes. Although central obesity was found to be predictive for stroke, baseline BMI 
was the only parameter of adiposity with a predictive value for NOAF. All the ultrasound 
indexes failed to predict NOAF. The current study did not confirm the predictive value of 
EFT for AF, which was found in some other studies [24, 25].  
A few major ultrasound indexes were used, which failed to predict NOAF or strokes. 
So far, carotid IMT was evidenced to have some predictive value for strokes [26, 27]. The 
were no previous studies, which assessed other fat depots in relation to stroke. Despite the 
link between visceral fat and stroke, the present study did not confirm the relation between 
abdominal visceral adipse tissue (AVF) and the risk of stroke. 
Epicardial fat and stroke 
Epicardial adipocytes originate from brown adipose tissue and they have been shown 
to produce various types of cytokines [28, 29]. It has the same blood supply as the 
myocardium, with a close anatomic and functional relationship as well. It is a fat depot related 
not only to local ventricle mass or function, but it is also related to visceral adiposity and 
cardiometabolic risk [30, 31]. Epicardial fat is also involved in the pathogenesis of insulin 
resistance through endothelial function, insulin-mediated vasoreactivity, and muscle perfusion 
[32]. The EFT may be increased as a consequence of adipocytes’ dysfunction and muscle 
proliferation [33]. Visceral obesity and an increasing number of adipocytes may induce a 
hypoxia and a pro-inflammatory state [33]. Moreover, increased release of pro-inflammatory 
cytokines induce lipolysis, oxidative stress and apoptosis within various depots of visceral 
adipose tissue [34]. Finally, excessive serum fatty acids link epicardial adipocytes, altered 
cardiac repolarization and arrhythmias [23]. Previous studies also suggest a link between EFT 
and the development of left atrial myopathy, increasing the risk of AF [35, 36]. Recent studies 
have shown that increased epicardial adiposity can directly modulate the electrophysiological 
properties of the heart and ion currents, causing higher arrhythmogenesis in left atrial 
myocytes, which contributes to an increased risk of AF [37]. There is also a well-established 
relation between general obesity, left atrial enlargement and changes in the histology of the 
atrial wall [38].   
 
Limitations of the study 
The present data regarding prospective clinical follow-up originated from the National 
Health System which collects reports from all the medical centers. There was no prospective 
visit or active testing for unknown AF in the study. Therefore, some patients of the study 
could have undetected AF, which could have affected the present results. There is also a 
possibility that an undiagnosed stroke could have been a cause of death, which was not 
known, reported to NHS and was included in the analysis. However, this is also true for other 
similar studies.   
 
CONCLUSIONS 
This is the first study providing important results based on a comprehensive 
assessment of various ultrasound indexes reflecting vascular indexes or fat depots and a 
prospective follow-up. It was found that age, WC and echocardiographic EFT revealed 
significant predictive values for stroke. Both WC and EFT showed a very high NPV 
suggesting that they should be implemented into the clinical practice as a tool affirming a very 
low risk of stroke.  
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Figure 1. The receiver operating characteristics (ROC) curves representing selected clinical 
parameters and ultrasound indexes with significant prediction of stroke; EFT — epicardial fat 
thickness; PATIMA — periarterial adipose tissue intima media adventitia, WC — waist 
circumference; WHR — waist-hip ratio. 
 
 
Table 1. Clinical characteristics of the study group. 
  
 Mean ± SD or no. (%) 
Age [years] 61.3 ± 7.2 
Female/male 131 (36%)/233 (64%) 
Diabetes 130 (36%) 
Lipid-lowering treatment 364 (100%) 
Total cholesterol [mg/dL] 175 ± 45 
LDL-C [mg/dL] 102 ± 41 
HDL-C [mg/dL] 44 ± 12 
Triglycerides [mg/dL] 141 ± 84 
Hypertension 325 (89%) 
Chronic kidney disease  17 (5%) 
Coronary artery disease 255 (70%) 
Prior myocardial infarction 77 (21%) 
Peripheral artery disease 82 (22%) 
Carotid artery stenosis ≥ 50% 51 (14%) 
Prior stroke 22 (6%) 
Smoker or ex-smoker  258 (71%) 
Body mass index [kg/m2] 30.8 ± 6 
Obesity 182 (50%) 
Risk factors  4.8 ± 1.5 
Very high/high CV risk  302 (83%)/62 (17%) 
CV — cardiovascular; LDL-C — low density lipoprotein cholesterol; HDL-C — high density 
lipoprotein cholesterol; SD — standard deviation 
 
Table 1. Ultrasound indexes of cardiovascular risk. 
   
  Mean ± SD or no. (%) 
Abdominal visceral fat [mm] 76 ± 26 
Abdominal subcutaneous fat [mm] 27.5 ± 11 
Carotid intima media thickness [µm] 915 ± 360 
Carotid extra media thickness [µm]  793 ± 124 
Epicardial fat thickness [mm] 3.51 ± 1.53 
Pericardial fat thickness [mm] 9 ± 6.3 
PATIMA combined index [u] 211 ± 96 
PATIMA — periarterial adipose tissue intima media adventitia; SD — standard deviation 
 
Tables 3. The baseline characteristics and ultrasound indexes in prediction of clinical events in the receiver 
operating characteristics (ROC) analysis.  
     
  Stroke Atrial fibrillation 
  AUC P AUC P 
Age 0.661 0.002 0.557 0.32 
Total number of CV risk factors 0.535 0.57 0.5 0.98 
LDL-C 0.571 0.2 0.527 0.62 
Triglycerides 0.636 0.1 0.501 0.9 
Body mass index 0.542 0.45 0.694 0.001 
Body fat 0.517 0.8 0.555 0.38 
Waist circumference 0.640 0.01 0.602 0.09 
Waist-hip ratio 0.659 0.01 0.515 0.8 
Abdominal visceral fat 0.577 0.15 0.540 0.47 
Abdominal subcutaneous fat 0.526 0.6 0.6 0.09 
Carotid intima media thickness 0.591 0.13 0.538 0.52 
Carotid extra media thickness 0.540 0.5 0.503 0.95 
Epicardial fat thickness 0.672 < 0.01 0.556 0.45 
Pericardial fat thickness 0.513 0.8 0.520 0.7 
PATIMA combined index 0.658 < 0.01 0.563 0.39 
AUC — area under curve; CV — cardiovascular; LDL-C — low density lipoprotein cholesterol; PATIMA — periarterial adipose tissue intima 
media adventitia  
